Agilon Health(AGL)
$90.53-24.67 (-21.41%)
AGL
Agilon Health financials statements
$90.53
At close:-24.67 (-21.41%)
Want to see AGL full AI Analyst Report?
Agilon Health (AGL) Ratios
393 Followers
Agilon Health Ratios
AGL's free cash flow for Q3 2026 was $46.62M. For the 2026 fiscal year, AGL's free cash flow was decreased by $-3.26M and operating cash flow was $49.87M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.02 | 1.27 | 1.51 | 2.71 | 3.83 |
| Quick Ratio | 1.02 | 1.27 | 1.51 | 2.71 | 3.83 |
| Cash Ratio | 0.16 | 0.17 | 0.12 | 0.87 | 2.96 |
| Solvency Ratio | -0.33 | -0.19 | -0.22 | -0.14 | -0.79 |
| Operating Cash Flow Ratio | -0.10 | -0.05 | -0.16 | -0.24 | -0.42 |
| Short-Term Operating Cash Flow Coverage | -5.50 | -23.49 | -17.17 | -26.16 | -17.84 |
| Net Current Asset Value | $ -47.86M | $ 194.74M | $ 400.23M | $ 794.41M | $ 872.54M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 |
| Debt-to-Equity Ratio | 0.29 | 0.09 | 0.08 | 0.05 | 0.05 |
| Debt-to-Capital Ratio | 0.23 | 0.09 | 0.07 | 0.05 | 0.05 |
| Long-Term Debt-to-Capital Ratio | 0.11 | 0.07 | 0.05 | 0.04 | 0.04 |
| Financial Leverage Ratio | 10.03 | 3.68 | 2.63 | 1.63 | 1.45 |
| Debt Service Coverage Ratio | -14.30 | -25.43 | -10.69 | -7.81 | -25.12 |
| Interest Coverage Ratio | -63.41 | -47.29 | -34.87 | -23.50 | -60.57 |
| Debt to Market Cap | 0.12 | 0.05 | 0.01 | 0.01 | 0.01 |
| Interest Debt Per Share | 2.62 | 3.05 | 0.14 | 0.14 | 0.18 |
| Net Debt to EBITDA | 0.37 | 0.69 | 0.37 | 5.70 | 2.75 |
| Profitability Margins | |||||
| Gross Profit Margin | -3.18% | 0.08% | 1.61% | 4.66% | 4.32% |
| EBIT Margin | -6.70% | -4.00% | -4.35% | -3.61% | -24.77% |
| EBITDA Margin | -6.22% | -3.60% | -3.88% | -3.03% | -23.80% |
| Operating Profit Margin | -7.10% | -4.82% | -5.38% | -4.41% | -24.47% |
| Pretax Profit Margin | -6.81% | -4.11% | -4.51% | -3.80% | -25.17% |
| Net Profit Margin | -6.83% | -4.29% | -6.08% | -4.46% | -26.72% |
| Continuous Operations Profit Margin | -6.83% | -4.13% | -4.52% | -3.87% | -25.23% |
| Net Income Per EBT | 100.31% | 104.55% | 135.04% | 117.52% | 106.14% |
| EBT Per EBIT | 95.97% | 85.18% | 83.77% | 86.04% | 102.88% |
| Return on Assets (ROA) | -31.88% | -15.00% | -15.08% | -6.28% | -25.63% |
| Return on Equity (ROE) | -319.84% | -55.24% | -39.68% | -10.23% | -37.23% |
| Return on Capital Employed (ROCE) | -216.15% | -50.20% | -30.40% | -9.07% | -30.28% |
| Return on Invested Capital (ROIC) | -196.72% | -49.98% | -30.04% | -9.03% | -30.08% |
| Return on Tangible Assets | -33.62% | -15.89% | -15.89% | -6.36% | -27.29% |
| Earnings Yield | -142.16% | -33.32% | -5.12% | -1.62% | -4.04% |
| Efficiency Ratios | |||||
| Receivables Turnover | 8.80 | 5.96 | 4.58 | 4.85 | 5.19 |
| Payables Turnover | 5.79 | 5.27 | 4.39 | 4.76 | 4.18 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 233.41 | 164.01 | 105.31 | 74.74 | 72.80 |
| Asset Turnover | 4.67 | 3.50 | 2.48 | 1.41 | 0.96 |
| Working Capital Turnover Ratio | 36.40 | 14.99 | 6.08 | 2.48 | 2.93 |
| Cash Conversion Cycle | -21.59 | -8.04 | -3.51 | -1.41 | -17.03 |
| Days of Sales Outstanding | 41.45 | 61.25 | 79.70 | 75.25 | 70.39 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 63.04 | 69.29 | 83.20 | 76.66 | 87.42 |
| Operating Cycle | 41.45 | 61.25 | 79.70 | 75.25 | 70.39 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -6.39 | -3.51 | -0.38 | -0.32 | -0.40 |
| Free Cash Flow Per Share | -7.19 | -4.32 | -0.46 | -0.40 | -0.43 |
| Dividend Paid and CapEx Coverage Ratio | -7.99 | -4.36 | -5.07 | -4.01 | -11.04 |
| Capital Expenditure Coverage Ratio | -7.99 | -4.36 | -5.07 | -4.01 | -11.04 |
| Operating Cash Flow Coverage Ratio | -2.87 | -1.31 | -2.99 | -2.49 | -2.49 |
| Operating Cash Flow to Sales Ratio | -0.02 | -0.01 | -0.04 | -0.05 | -0.10 |
| Free Cash Flow Yield | -41.74% | -9.10% | -3.64% | -2.48% | -1.60% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.70 | -3.02 | -19.54 | -61.82 | -24.77 |
| Price-to-Sales (P/S) Ratio | 0.05 | 0.13 | 1.19 | 2.76 | 6.62 |
| Price-to-Book (P/B) Ratio | 2.25 | 1.66 | 7.75 | 6.33 | 9.22 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -2.40 | -10.99 | -27.44 | -40.30 | -62.31 |
| Price-to-Operating Cash Flow Ratio | -2.70 | -13.51 | -32.85 | -50.36 | -67.96 |
| Price-to-Earnings Growth (PEG) Ratio | -0.01 | 1.93 | -0.13 | 0.81 | -0.04 |
| Enterprise Value Multiple | -0.40 | -2.89 | -30.24 | -85.27 | -25.06 |
| Enterprise Value | 148.24M | 630.94M | 5.07B | 6.17B | 9.07B |
| EV to EBITDA | -0.40 | -2.89 | -30.24 | -85.27 | -25.06 |
| EV to Sales | 0.02 | 0.10 | 1.17 | 2.59 | 5.96 |
| EV to Free Cash Flow | -1.25 | -8.88 | -27.11 | -37.77 | -56.16 |
| EV to Operating Cash Flow | -1.40 | -10.92 | -32.46 | -47.21 | -61.24 |
| Tangible Book Value Per Share | 3.68 | 22.75 | 1.40 | 2.50 | 2.67 |
| Shareholders’ Equity Per Share | 7.65 | 28.65 | 1.62 | 2.55 | 2.93 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | -0.01 | -0.00 | -0.02 | -0.00 |
| Revenue Per Share | 358.27 | 368.68 | 10.56 | 5.85 | 4.08 |
| Net Income Per Share | -24.48 | -15.83 | -0.64 | -0.26 | -1.09 |
| Tax Burden | 1.00 | 1.05 | 1.35 | 1.18 | 1.06 |
| Interest Burden | 1.02 | 1.03 | 1.04 | 1.05 | 1.02 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.04 | 0.04 | 0.07 | 0.09 | 0.28 |
| Stock-Based Compensation to Revenue | 0.01 | 0.01 | 0.02 | 0.01 | 0.19 |
| Income Quality | 0.27 | 0.22 | 0.59 | 1.22 | 0.36 |
Currency in USD

